Search

Your search keyword '"Neovascularization, Physiologic drug effects"' showing total 17 results
Start Over Descriptor "Neovascularization, Physiologic drug effects" Publication Type Magazines
17 results on '"Neovascularization, Physiologic drug effects"'

1. Semaphorin3A is a promising therapeutic tool for bronchial asthma.

Author

Toubi E and Vadasz Z

Subjects
Animals, Asthma blood, Bronchoalveolar Lavage Fluid, Disease Models, Animal, Eosinophils immunology, Humans, Lung immunology, Lung pathology, Mice, Mice, Inbred BALB C, Neovascularization, Physiologic drug effects, Neutrophils immunology, Recombinant Proteins blood, Recombinant Proteins therapeutic use, Semaphorin-3A blood, Semaphorin-3A pharmacology, Treatment Outcome, Vascular Endothelial Growth Factor A antagonists & inhibitors, Asthma drug therapy, Semaphorin-3A administration & dosage
Published
2020
Full Text
View/download PDF

2. VEGF mimic provides potential strategy for blood vessel growth and ischemic tissue repair.

Subjects
Blood Vessels drug effects, Blood Vessels growth & development, Endothelial Growth Factors, Humans, Infant, Newborn, Myocardial Infarction, Nanostructures, Plaque, Amyloid diagnosis, Regenerative Medicine trends, Wound Healing, Anemia, Sickle Cell diagnosis, Hemoglobins analysis, Molecular Mimicry, Neovascularization, Physiologic drug effects, Prealbumin analysis, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization methods, Vascular Endothelial Growth Factor A chemistry, Vascular Endothelial Growth Factor A therapeutic use
Published
2011
Full Text
View/download PDF

3. Taking thalidomide out of rehab.

Author

Akhurst RJ

Subjects
Animals, Endothelial Cells drug effects, Epistaxis etiology, Humans, Mice, Neovascularization, Physiologic drug effects, Telangiectasia, Hereditary Hemorrhagic complications, Thalidomide pharmacology, Epistaxis drug therapy, Telangiectasia, Hereditary Hemorrhagic drug therapy, Thalidomide therapeutic use
Published
2010
Full Text
View/download PDF

4. A direct, non-canonical pathway for Hedgehog proteins in the endothelium.

Author

Zhao Q, Beck A, and Fraidenraich D

Subjects
Endothelial Cells cytology, Endothelial Cells enzymology, Humans, Neovascularization, Physiologic drug effects, Patched Receptors, Receptors, Cell Surface metabolism, Receptors, G-Protein-Coupled metabolism, Signal Transduction, Smoothened Receptor, rhoA GTP-Binding Protein metabolism, Endothelial Cells drug effects, Hedgehog Proteins pharmacology
Published
2010

5. Hedgehog takes a new "RHOad" to angiogenesis.

Author

Fernandez-Zapico ME

Subjects
Endothelial Cells metabolism, Humans, Receptors, G-Protein-Coupled metabolism, Smoothened Receptor, rac1 GTP-Binding Protein metabolism, rhoA GTP-Binding Protein metabolism, Hedgehog Proteins pharmacology, Neovascularization, Physiologic drug effects
Published
2010
Full Text
View/download PDF

6. [Role of Adrenomedullin in vasculogenesis and lymphangiogenesis: a new concept].

Author

Ouafik L and Martin PM

Subjects
Adrenomedullin genetics, Blood Vessels cytology, Cell Differentiation, Humans, Lymphangiogenesis genetics, Lymphatic Vessels cytology, Lymphatic Vessels physiology, Neovascularization, Physiologic drug effects, Adrenomedullin physiology, Blood Vessels physiology, Lymphangiogenesis physiology, Neovascularization, Physiologic physiology
Published
2008
Full Text
View/download PDF

7. Drug discovery: a lifeline for suffocating tissues.

Author

Mazzone M and Carmeliet P

Subjects
Animals, Blood Vessels cytology, Blood Vessels drug effects, Blood Vessels growth & development, Ischemia metabolism, Ischemia pathology, Mice, Nitric Oxide adverse effects, Nitric Oxide metabolism, Nitrites metabolism, Ischemia drug therapy, Neovascularization, Physiologic drug effects, Nitrites pharmacology, Nitrites therapeutic use
Published
2008
Full Text
View/download PDF

8. Cardiovascular biology: signalling silenced.

Author

Conway EM and Carmeliet P

Subjects
Endothelial Growth Factors pharmacology, Humans, Intercellular Signaling Peptides and Proteins pharmacology, Lymphokines pharmacology, Matrix Metalloproteinase Inhibitors, Matrix Metalloproteinases metabolism, Neoplasms blood supply, Neoplasms drug therapy, Receptor Protein-Tyrosine Kinases metabolism, Receptor, Fibroblast Growth Factor, Type 2, Receptors, Fibroblast Growth Factor metabolism, Receptors, Vascular Endothelial Growth Factor metabolism, Tissue Inhibitor of Metalloproteinase-2 genetics, Tissue Inhibitor of Metalloproteinase-2 pharmacology, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factors, Neovascularization, Physiologic drug effects, Receptor Protein-Tyrosine Kinases antagonists & inhibitors, Receptors, Fibroblast Growth Factor antagonists & inhibitors, Receptors, Vascular Endothelial Growth Factor antagonists & inhibitors, Signal Transduction drug effects, Tissue Inhibitor of Metalloproteinase-2 metabolism
Published
2003
Full Text
View/download PDF

10. Towards therapeutic angiogenesis.

Author

Singhal MK

Subjects
Animals, Becaplermin, Endothelial Growth Factors pharmacology, Fibroblast Growth Factors pharmacology, Humans, Intercellular Signaling Peptides and Proteins pharmacology, Lymphokines pharmacology, Platelet-Derived Growth Factor pharmacology, Proto-Oncogene Proteins c-sis, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factors, Neovascularization, Physiologic drug effects
Published
2002

11. Growing better blood vessels.

Author

Carmeliet P and Conway EM

Subjects
Animals, Becaplermin, Blood Vessels physiology, Delayed-Action Preparations administration & dosage, Drug Synergism, Endothelial Growth Factors administration & dosage, Humans, Kinetics, Lymphokines administration & dosage, Mice, Models, Biological, Platelet-Derived Growth Factor administration & dosage, Polymers administration & dosage, Proto-Oncogene Proteins c-sis, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factors, Blood Vessels drug effects, Drug Delivery Systems methods, Neovascularization, Physiologic drug effects
Published
2001
Full Text
View/download PDF

12. Too many vessels? Not enough? The wrong kind? The VEGF debate continues.

Author

Ware JA

Subjects
Animals, Arteriosclerosis etiology, Clinical Trials as Topic, Endothelial Growth Factors adverse effects, Endothelial Growth Factors physiology, Humans, Lymphokines adverse effects, Lymphokines physiology, Myocardial Ischemia drug therapy, Neovascularization, Pathologic, Safety, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factors, Endothelial Growth Factors pharmacology, Lymphokines pharmacology, Neovascularization, Physiologic drug effects
Published
2001
Full Text
View/download PDF

13. American Heart Association 2000: Touching Hearts Through Science.

Author

SoRelle R

Subjects
Aged, Bone Marrow Transplantation, Cell Differentiation genetics, Cell Transplantation, Dose-Response Relationship, Drug, Endothelial Growth Factors pharmacology, Endothelial Growth Factors therapeutic use, Health Services Accessibility, Heart Diseases economics, Humans, Lymphokines pharmacology, Lymphokines therapeutic use, Myocardial Contraction, Myocardium cytology, Neovascularization, Physiologic drug effects, Stem Cell Transplantation, Stromal Cells transplantation, United States, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factors, American Heart Association, Heart Diseases genetics, Heart Diseases therapy
Published
2000

14. VEGF gene therapy: stimulating angiogenesis or angioma-genesis?

Author

Carmeliet P

Subjects
Animals, Dose-Response Relationship, Drug, Endothelial Growth Factors genetics, Gene Expression Regulation, Heart embryology, Heart physiology, Heart Neoplasms genetics, Humans, Lymphokines genetics, Mice, Neovascularization, Physiologic physiology, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factors, Endothelial Growth Factors pharmacology, Genetic Therapy methods, Hemangioma genetics, Lymphokines pharmacology, Neovascularization, Physiologic drug effects
Published
2000
Full Text
View/download PDF

15. Tumor angiogenesis. Gene expression patterns identified.

Author

Marx J

Subjects
Angiogenesis Inhibitors genetics, Angiogenesis Inhibitors pharmacology, Antineoplastic Agents pharmacology, Colon metabolism, Colonic Neoplasms genetics, Colonic Neoplasms pathology, Endothelium, Vascular cytology, Endothelium, Vascular pathology, Gene Expression, Humans, Neovascularization, Physiologic drug effects, Colon blood supply, Colonic Neoplasms blood supply, Endothelium, Vascular metabolism, Gene Expression Profiling, Neovascularization, Pathologic genetics
Abstract

Researchers have obtained the most detailed sketch yet of how cancerous tumors secure the blood supplies that nourish their growth. On page 1197, a team reports the results of a large-scale comparison of the genes expressed in the blood vessels of human colon cancers and of normal colon tissue. They've found that the gene expression patterns of the two types of vasculature are distinctly different. The findings could help researchers develop new anticancer drugs that work by homing in on the protein products of genes that are overexpressed in tumor vessels, thus shutting off the growth of blood vessels the tumor needs to survive.

Published
2000
Full Text
View/download PDF

16. Leaky vessels? Call Ang1!

Author

Jain RK and Munn LL

Subjects
Angiopoietin-1, Animals, Endothelial Growth Factors genetics, Endothelial Growth Factors pharmacology, Lymphokines genetics, Lymphokines pharmacology, Membrane Glycoproteins pharmacology, Mice, Mice, Knockout, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factors, Capillary Permeability drug effects, Endothelial Growth Factors administration & dosage, Lymphokines administration & dosage, Membrane Glycoproteins administration & dosage, Neovascularization, Physiologic drug effects
Published
2000
Full Text
View/download PDF

17. Cartilage to bone--angiogenesis leads the way.

Author

Harper J and Klagsbrun M

Subjects
Animals, Chondrocytes drug effects, Humans, Neovascularization, Physiologic drug effects, Proto-Oncogene Proteins genetics, Proto-Oncogene Proteins metabolism, Proto-Oncogene Proteins pharmacology, Receptor Protein-Tyrosine Kinases genetics, Receptor Protein-Tyrosine Kinases metabolism, Receptor Protein-Tyrosine Kinases pharmacology, Receptors, Growth Factor metabolism, Receptors, Vascular Endothelial Growth Factor, Vascular Endothelial Growth Factor A, Vascular Endothelial Growth Factor Receptor-1, Vascular Endothelial Growth Factors, Bone and Bones physiology, Cartilage physiology, Chondrocytes physiology, Endothelial Growth Factors physiology, Growth Plate physiology, Lymphokines physiology, Neovascularization, Physiologic physiology
Published
1999
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results